UNICREDIT BANK/CALL/ROCHE GS/220/0.1/18.12.24 Share Price

Warrant

DE000HD0TRJ2

Real-time BOERSE MUENCHEN 08:45:00 01/07/2024 BST
3.5 EUR -1.41% Intraday chart for UNICREDIT BANK/CALL/ROCHE GS/220/0.1/18.12.24
Current month+63.59%
1 month+82.99%
Date Price Change
01/07/24 3.5 -1.41%
28/06/24 3.55 -2.20%
27/06/24 3.63 +1.11%
26/06/24 3.59 -9.11%
25/06/24 3.95 -1.99%

Real-time BOERSE MUENCHEN

Last update July 01, 2024 at 08:45 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer UniCredit UniCredit
WKN HD0TRJ
ISINDE000HD0TRJ2
Date issued 20/11/2023
Strike 220 CHF
Maturity 18/12/2024 (171 Days)
Parity 10 : 1
Emission price 2.73
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.18
Lowest since issue 1.14
Delta0.85x
Omega 6.316
Premium1.64x
Gearing7.39x
Moneyness 1.135
Difference Strike -30.1 CHF
Difference Strike %-13.68%
Spread 0.02
Spread %0.57%
Theoretical value 3.520
Implied Volatility 19.80 %
Total Loss Probability 17.68 %
Intrinsic value 3.097
Present value 0.4231
Break even 254.10 €
Theta-0.02x
Vega0.04x
Rho0.09x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.5 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.44%
Consensus